Adrenal Disorders Flashcards
What is an adrenal adenoma
benign cancer emerging from the cells of the adrenal cortex
Associations with adrenal adenoma
Increase in frequency with age
Histological features of an adrenal adenoma
Well differentiated small, solitary lesions
Bright yellow and buried within the gland
How do patients usually get a diagnosis of adrenal adenoma
Often an incidental finding during abdominal imaging
How do patients with hyperfunctioning adrenal adenoma present
Excess hormone secretion e.g. cushings, conn syndrome
Investigations for adrenal adenoma
CT, MRI
hormonal testing
Management of adrenal adenoma without biochemical abnormality
Can be left in situ
When may a surgical excision of an adrenal adenoma be required
Lesion is functioning
Lesion is large - can be considered potentially malignant
What is an adrenocortical carcinoma
Very rare malignancy of the adrenal cortex
What is adrenocortical carcinoma associated with in young patients
Li-fraumeni syndrome
Histological features of an adrenocortical carcinoma
Large
Haemorrhage and necrosis
Capsular or vascular invasion
Local invasion of adrenocortical carcinoma
Retroperitoneum
Kidney
Metastasis of adrenocortical carcinoma
Usually haematogenous to the liver, lung and bone
Clinical presentation of adrenocortical carcinoma
Hormonal effects, abdominal mass effects
Carcinomas with necrosis can cause fever
Imaging of adrenocortical carcinoma
CT or MRI
Management of adrenocortical carcinoma
Resection with adjuvant therapy
What is neuroblastoma
Malignant neuroendocrine tumour of the sympathetic nervous system
Where does a neuroblastoma originate from
Neural crest cells
Mean age of diagnosis of a neuroblastoma
23 months
Symptoms of neuroblastoma
Loss of appetite
Vomiting
Weight loss
Fatigue
Bone pain
Bloods in neuroblastoma
Anaemia, raised inflammatory markers, abnormal coag
Investigations for neuroblastoma
Bloods, biopsy, CT
Management of neuroblastoma in low risk patients
Observed for spontaneous resolution or local resection
Management of neuroblastoma in high risk patients
Multi-agent chemotherapy, surgery and radiotherapy